Routine Coagulation Testing Methods Compared
|
By LabMedica International staff writers Posted on 13 Jun 2012 |
|
Coagulation testing can be estimated using two different detection methodologies; one is an optical method and the other a mechanical system.
Coagulation analyzers run the range of options, from automated instruments to manual devices, from high-volume processing to low-volume analysis, and from a wide selection of assays to a small, core group of tests.
Scientists at the Memorial Hospital (Istanbul, Turkey) assayed prothrombin time (PT) and activated partial thromboplastin time (aPTT) on the Coag-a-mate MTX II automated photooptical coagulation analyzer and the AMAX 200 automated photo-mechanical coagulation analyzer. A total of 424 patient samples were included in the study during a period of 15 days and plasma from 25 normal healthy individuals was assayed to obtain the geometric means and reference ranges for PT and aPTT for both the MTX II and AMAX 200 instruments which are marketed by TrinityBioTech (Berkeley Heights, NJ, USA).
The results of the coagulation tests showed good precision ranging between 0.7% and 1.8% coefficient of variation. Statistical analysis demonstrated an excellent correlation between the photooptical and mechanical analyzers for PT and aPTT. Plasma samples from 25 healthy normal donors yielded the following reference ranges: for PT, 10.5-12.3 seconds for MTX II and 11.3-13.4 seconds for the AMAX 200. The ranges for the aPTT were 24.5-33.9 seconds for MTX II and 25.5-35.8 seconds for the AMAX 200.
The authors concluded that all data obtained during the study indicate that the patient results obtained by the photooptical detection system are as reliable and statistically equivalent as those obtained using the mechanical detection system. Most notably, they also found that when testing suboptimal samples, such as those with hyperbilirubinemia or lipemia, the photooptical and mechanical detection methods are statistically equivalent. The study was published in the May 2012 issue of the Journal of Clinical Laboratory Analysis.
Related Links:
Memorial Hospital
TrinityBioTech
Coagulation analyzers run the range of options, from automated instruments to manual devices, from high-volume processing to low-volume analysis, and from a wide selection of assays to a small, core group of tests.
Scientists at the Memorial Hospital (Istanbul, Turkey) assayed prothrombin time (PT) and activated partial thromboplastin time (aPTT) on the Coag-a-mate MTX II automated photooptical coagulation analyzer and the AMAX 200 automated photo-mechanical coagulation analyzer. A total of 424 patient samples were included in the study during a period of 15 days and plasma from 25 normal healthy individuals was assayed to obtain the geometric means and reference ranges for PT and aPTT for both the MTX II and AMAX 200 instruments which are marketed by TrinityBioTech (Berkeley Heights, NJ, USA).
The results of the coagulation tests showed good precision ranging between 0.7% and 1.8% coefficient of variation. Statistical analysis demonstrated an excellent correlation between the photooptical and mechanical analyzers for PT and aPTT. Plasma samples from 25 healthy normal donors yielded the following reference ranges: for PT, 10.5-12.3 seconds for MTX II and 11.3-13.4 seconds for the AMAX 200. The ranges for the aPTT were 24.5-33.9 seconds for MTX II and 25.5-35.8 seconds for the AMAX 200.
The authors concluded that all data obtained during the study indicate that the patient results obtained by the photooptical detection system are as reliable and statistically equivalent as those obtained using the mechanical detection system. Most notably, they also found that when testing suboptimal samples, such as those with hyperbilirubinemia or lipemia, the photooptical and mechanical detection methods are statistically equivalent. The study was published in the May 2012 issue of the Journal of Clinical Laboratory Analysis.
Related Links:
Memorial Hospital
TrinityBioTech
Gold Member
Automatic Hematology Analyzer
CF9600
HPV Test
Allplex HPV28 Detection
POC Immunoassay Analyzer
Procise DX
Latest Hematology News
- Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
- Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
- Higher Ferritin Threshold May Improve Iron Deficiency Detection in Children
- Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
- Advanced CBC-Derived Indices Integrated into Hematology Platforms
- Blood Test Enables Early Detection of Multiple Myeloma Relapse
- Single Assay Enables Rapid HLA and ABO Genotyping for Transplant Matching
- Prognostic Biomarker Identified in Diffuse Large B-Cell Lymphoma
- Routine Blood Test Parameters Link Anemia to Cancer Risk and Mortality
- Prognostic Tool Guides Personalized Treatment in Rare Blood Cancer
- New Platelet Function Assay Enables Monitoring of Antiplatelet Therapy
- Open Multi-Omics Platform Identifies Prognostic Subtypes in Blood Cancers
- AI-Powered Digital Workflow Standardizes Bone Marrow Aspirate Morphology
- Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
- New Guidelines Aim to Improve AL Amyloidosis Diagnosis
- Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read more
Molecular Diagnostics
view channel
Blood Test Predicts Immunotherapy Response in Head and Neck Cancer
Head and neck squamous cell carcinoma affects hundreds of thousands of people worldwide each year, yet response rates to immunotherapy remain low. Clinicians lack reliable, minimally invasive tools to... Read more
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read more
Immunology
view channel
Aptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read more
Microbiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read more
Pathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read more
Technology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read more
Industry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more
